tiprankstipranks
Trending News
More News >
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
US Market

Madrigal Pharmaceuticals (MDGL) Income Statement

Compare
1,316 Followers

Madrigal Pharmaceuticals Income Statement

Last quarter (Q3 2025), Madrigal Pharmaceuticals's total revenue was $287.27M, an increase of 362.03% from the same quarter last year. In Q3, Madrigal Pharmaceuticals's net income was $-114.19M. See Madrigal Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 180.13M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 173.90M$ -527.00K$ 0.00$ 0.00$ -471.00K
Operating Expenses
$ 671.77M$ 379.97M$ 293.57M$ 242.48M$ 205.85M
Depreciation and Amortization
$ 1.10M$ 527.00K$ 467.00K$ 405.00K$ 471.00K
EBITDA
$ -450.13M$ -360.39M$ -290.92M$ -241.44M$ -201.77M
Operating Income
$ -497.88M$ -380.50M$ -293.57M$ -242.48M$ -206.32M
Other Income/Expenses
$ 31.98M$ 6.87M$ -1.78M$ 636.00K$ 4.08M
Pretax Income
$ -465.89M$ -373.63M$ -295.35M$ -241.85M$ -202.24M
Net Income
$ -465.89M$ -373.63M$ -295.35M$ -241.85M$ -202.24M
Per Share Metrics
Basic EPS
$ -21.90$ -19.99$ -17.23$ -14.63$ -13.09
Diluted EPS
$ -21.90$ -19.99$ -17.23$ -14.63$ -13.09
Weighted Average Shares Outstanding
21.27M 18.69M 17.14M 16.54M 15.45M
Weighted Average Shares Outstanding (Diluted)
21.27M 18.69M 17.14M 16.54M 15.45M
Currency in USD

Madrigal Pharmaceuticals Earnings and Revenue History